In vitro and in vivo light dose rate effects related to hematoporphyrin derivative photodynamic therapy.

In vitro and in vivo experiments were performed to evaluate the parameter of light dose rate as it relates to the efficiency of hematoporphyrin derivative (HPD)-induced photosensitization. Exponentially growing Chinese hamster ovary cells were incubated with HPD (25 micrograms/ml) and were then exposed to red light (630 nm) delivered at different dose rates. A total of five dose rates (0.5, 5.0, 15, 23, and 60 milliwatts/sq cm) were examined following a 1-hr HPD incubation, two dose rates (1 and 20 milliwatts/sq cm) were examined after a 12-hr HPD incubation, and three dose rates (0.4, 4, and 40 milliwatts/sq cm) were examined following a 16-hr incubation and a 30-min serum wash protocol. The effect of light dose rate was determined from cell survival curves obtained by standard clonogenic colony formation assays. Similar levels of cellular toxicity were obtained when cells from each HPD incubation group were treated with equal doses of red light delivered at different dose rates. For in vivo experiments, albino mice were given injections of HPD (7.5 mg/kg) and 24 h later the right hind leg of each mouse was treated with localized red light (630 nm). A total dose of 270 J/sq cm was delivered to the right hind leg at dose rates of 5, 25, or 125 milliwatts/sq cm. The resulting acute skin damage induced by HPD photosensitization was scored over a 30-day period, and skin response curves for the three dose rates were obtained. Comparable levels of damage were induced in each of the three experimental groups. The results obtained from both in vitro and in vivo studies indicate that the photosensitizing efficiency of HPD photodynamic therapy is not affected by nonthermal variations in clinically relevant dose rates of delivered light.

[1]  M W Berns,et al.  Laser photoradiation therapy of cancer. , 1986, Cancer research.

[2]  C. Gomer,et al.  ACUTE SKIN RESPONSE IN ALBINO MICE FOLLOWING PORPHYRIN PHOTOSENSITIZATION UNDER OXIC AND ANOXIC CONDITIONS , 1984, Photochemistry and photobiology.

[3]  C J Gomer,et al.  ACTION SPECTRUM (620–640 nm) FOR HEMATOPORPHYRIN DERIVATIVE INDUCED CELL KILLING , 1984, Photochemistry and photobiology.

[4]  J. H. Kinsey,et al.  Treatment of transitional cell carcinoma of the bladder with hematoporphyrin derivative phototherapy. , 1983, The Journal of urology.

[5]  J. H. Kinsey,et al.  Thermal considerations in murine tumor killing using hematoporphyrin derivative phototherapy. , 1983, Cancer research.

[6]  J. H. Kinsey,et al.  Hematoporphyrin-Derivative Phototherapy for Local Treatment of Cancer of the Tracheobronchial Tree , 1982, The Annals of otology, rhinology, and laryngology.

[7]  G. Hahn Hyperthermia and Cancer , 1982, Springer US.

[8]  J. H. Kinsey,et al.  Photoradiation therapy in the treatment of malignant brain tumors: a phase I (feasibility) study. , 1981, Neurosurgery.

[9]  C. Gomer,et al.  PHOTOINACTIVATION OF CHINESE HAMSTER CELLS BY HEMATOPORPHYRIN DERIVATIVE AND RED LIGHT , 1980, Photochemistry and photobiology.

[10]  D. Kessel,et al.  Transport and binding of mesoporphyrin IX by leukemia L1210 cells. , 1980, Cancer research.

[11]  T J Dougherty,et al.  Photoradiation in the treatment of recurrent breast carcinoma. , 1979, Journal of the National Cancer Institute.

[12]  J E Kaufman,et al.  Photoradiation therapy for the treatment of malignant tumors. , 1978, Cancer research.

[13]  T J Dougherty,et al.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. , 1976, Cancer Research.

[14]  M. Snell,et al.  Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. , 1976, The Journal of urology.

[15]  J. Bedford,et al.  Dose-rate effects in synchronous mammalian cells in culture. , 1973, Radiation research.

[16]  B W Henderson,et al.  Enhanced tumor control following sequential treatments of photodynamic therapy (PDT) and localized microwave hyperthermia in vivo , 1984, Lasers in surgery and medicine.

[17]  R. Bruce Photoradiation of choroidal malignant melanoma. , 1984, Progress in clinical and biological research.

[18]  T. Dougherty Photodynamic therapy (PDT) of malignant tumors. , 1984, Critical reviews in oncology/hematology.

[19]  T. Dougherty,et al.  Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue. , 1979, Cancer research.

[20]  E. Hall,et al.  Radiobiology for the radiologist , 1973 .

[21]  A. M. Olsen,et al.  The use of a derivative of hematoporphyrin in tumor detection. , 1961 .